Tempest Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Tempest Therapeutics has a total shareholder equity of $11.5M and total debt of $8.5M, which brings its debt-to-equity ratio to 74.2%. Its total assets and total liabilities are $33.8M and $22.4M respectively.
Key information
74.2%
Debt to equity ratio
US$8.50m
Debt
| Interest coverage ratio | n/a |
| Cash | US$22.12m |
| Equity | US$11.46m |
| Total liabilities | US$22.38m |
| Total assets | US$33.84m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: TPST's short term assets ($23.6M) exceed its short term liabilities ($14.0M).
Long Term Liabilities: TPST's short term assets ($23.6M) exceed its long term liabilities ($8.4M).
Debt to Equity History and Analysis
Debt Level: TPST has more cash than its total debt.
Reducing Debt: Insufficient data to determine if TPST's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TPST has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TPST has less than a year of cash runway if free cash flow continues to reduce at historical rates of 8.3% each year